A 55-year-old woman arrived at an emergency department short of breath, her heart racing at 207 beats per minute, her oxygen saturation down to 86 percent, and weakness already showing along her right side. A bedside ultrasound found the reason within minutes, and it was moving. A clot roughly the size of a grape was tumbling loose inside the upper left chamber of her heart, bulging into her narrowed mitral valve every time the valve tried to open.
Her case was published in JACC: Case Reports by a team led by Astrid Karina Putri, with senior author Lucia Kris Dinarti, at Universitas Gadjah Mada and Dr. Sardjito General Hospital in Yogyakarta, Indonesia. The title the authors chose says most of it: mitral jamming.
Why a Clot That Moves Is a Different Kind of Problem
Most clots in the left side of the heart form in a predictable spot. The left atrial appendage, a small pouch off the upper left chamber, is where blood pools when the atrium quivers instead of contracting, which is what happens in atrial fibrillation. Clots that form there tend to stay put, anchored to the wall, and the danger is that a piece breaks off and travels to the brain.
A mobile clot behaves differently. It rolls. In a heart with a severely narrowed mitral valve, a free or loosely attached clot can be pushed toward the valve opening with each heartbeat and act like a stopper in a drain, a phenomenon cardiologists have long described as ball-valve obstruction. The blockage is intermittent, which is why some patients collapse suddenly and then recover, and why others deteriorate without warning.
That pattern runs through the case literature, and the outcomes are not uniformly good. A 75-year-old woman described in European Heart Journal Case Reports had a history of mild rheumatic mitral stenosis, had gone unmonitored for two decades, and was on no anticoagulation. She reached the emergency department after a near-fainting episode, deteriorated into cardiogenic shock, and died when the spherical mass in her left atrium lodged in the mitral valve and shut off flow into the ventricle entirely. A separate report of three cases from Morocco describes the same anatomy with two survivors and one death.
What the Echocardiogram Showed in the Indonesian Case
The bedside transthoracic echocardiogram found severe mitral stenosis with rheumatic heart disease morphology. The mitral valve area was 0.3 square centimeters, several times smaller than normal, with a mean gradient across the valve of 23.59 mm Hg. Her Wilkins score, which grades valve leaflet mobility, thickness, subvalvular thickening, and calcification, was 12, the maximum.
Sitting above that valve was a mobile clot measuring 24 by 24 millimeters that bulged toward the mitral opening throughout diastole, the phase when the valve should be letting blood through. The scan also showed severe tricuspid regurgitation, a pulmonary artery systolic pressure of 52 mm Hg, indicating high risk of pulmonary hypertension, and an enlarged left atrium with a preserved left ventricular ejection fraction of 55 percent.
Her electrocardiogram showed rapid atrial fibrillation. Her white cell count was elevated at 20,600 per microliter, and her liver transaminases were up. The right-sided weakness noted on examination reflected a stroke she had already sustained before anyone imaged her heart.
Surgeons performed an urgent mitral valve replacement together with the removal of the clot. She was discharged on day 39, with the prosthetic valve working normally at follow-up but with lasting neurological deficits from the embolic damage.
Rheumatic Heart Disease Is the Thread Running Through These Cases
The authors note that left atrial thrombus turns up in about 17 percent of patients with severe mitral stenosis, and that the rate roughly doubles when atrial fibrillation is also present. Mitral stenosis at that severity is now overwhelmingly a consequence of rheumatic heart disease, the long-term valve damage that follows untreated or repeated streptococcal infection in childhood.
That is why cases like this one cluster in countries where rheumatic fever remains common and why they have become less familiar to American clinicians, though they have not disappeared. Immigrants and older adults who grew up before widespread antibiotic treatment still present with rheumatic valve disease in United States hospitals.
Anticoagulation is the first-line answer for most left atrial clots, but it is not reliably sufficient. A separate JACC case described a 72-year-old woman with moderate mitral stenosis and atrial flutter who had kept a therapeutic INR above 2.5 for more than a year on warfarin and still turned out to have a large thrombus completely occluding her left atrial appendage on transesophageal echocardiogram, found during the workup before a planned cardioversion.
What the Case Actually Establishes, and What It Does Not
This is a single case report, the lowest rung of clinical evidence. It cannot tell anyone how often mobile left atrial clots occur, how often they obstruct, or how best to manage them. What it does is document a recognizable emergency pattern and demonstrate that a bedside ultrasound, available in most emergency departments, can identify it fast.
The authors' take-home point is narrow and practical. In a patient with acute, progressive breathlessness, echocardiography is the first-line test capable of detecting both severe mitral stenosis and a mobile clot simultaneously, and when the clot obstructs the valve, urgent surgery rather than watchful anticoagulation may be what saves the patient.
Nothing here changes the standing medical guidance for people already on blood thinners for atrial fibrillation. People with known valve disease or atrial fibrillation who develop sudden breathlessness, fainting, or one-sided weakness should seek emergency care, and anyone with questions about their own anticoagulation should raise them with their cardiologist rather than adjust anything independently.
Key Questions Answered
What is a left atrial mobile thrombus?
A blood clot in the heart's upper left chamber that is free-floating or only loosely attached, so it moves with each heartbeat instead of staying fixed to the wall.
Why is a moving clot more dangerous than a fixed one?
It can be pushed into a narrowed mitral valve, intermittently blocking blood flow, and it can also break free and travel to the brain or other organs.
How common is this?
Left atrial thrombus is reported in roughly 17 percent of patients with severe mitral stenosis, with the rate about doubling when atrial fibrillation is present. Mobile ball-type clots are far rarer and are mostly documented in individual case reports.
Who is at risk?
Chiefly, people with rheumatic mitral stenosis, prosthetic mitral valves, or atrial fibrillation. This is not a risk for the general population.
What symptoms should prompt emergency care?
Sudden or worsening breathlessness, fainting, chest pain, palpitations, or weakness on one side of the body in someone with known valve disease or an irregular heartbeat.
Do blood thinners prevent this?
They substantially reduce risk but do not eliminate it. Published case reports describe large clots forming in patients whose anticoagulation levels were within the target range.
